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ABSTRACT
Background
Clinical guidelines advise screening for depression in
patients with diabetes. The Patient Health
Questionnaire (PHQ-9) and the depression subscale of
the Hospital Anxiety and Depression Scale (HADS-D)
are commonly used in primary care.
Aim
To compare the efficacy of HADS-D and PHQ-9 in
identifying moderate to severe depression among
primary care patients with type 2 diabetes.
Design of study
Self-report postal survey, clinical records assessed by
GPs.
Setting
Seven metropolitan and rural general practices in
Victoria, Australia.
Method
Postal questionnaires were sent to all patients with
diabetes on the registers of seven practices in Victoria.
A total of 561 completed postal questionnaires were
returned, giving a response rate 47%. Surveys
included demographic information, and history of
diabetes and depression. Participants completed both
the PHQ-9 and HADS-D. Clinical data from patient
records included glycosylated hemoglobin (HbA1c)
levels and medications.
Results
The proportion of the total sample completing HADS-D
was 96.8% compared with 82.4% for PHQ-9. Level of
education was unrelated to responses on the HADS-D
but was related to completion of the PHQ-9. Using
complete data (n = 456) from both measures, 40
responders showed HADS-D scores in the moderate to
severe range, compared with 103 cases identified by
PHQ-9. Only 35 cases were classified in the moderate
to severe category by both the PHQ-9 and HADS-D.
Items with the highest proportions of positive responses
on the PHQ-9 were related to tiredness and sleeping
problems and, on the HADS-D, feeling slowed down.
Conclusion
It may be that the items contributing to the higher
prevalence of moderate to severe depression using the
PHQ-9 are due to diabetes-related symptoms or sleep
disorders.
Keywords
depression; diabetes; Hospital Anxiety and Depression
Scale; Patient Health Questionnaire; sleep disturbance.
INTRODUCTION
Diabetes is a major contributor to the global burden
of disease and a growing number of studies show
links between depression and diabetes.1–3 The
negative impact depression can have on quality of
life for people with diabetes, together with the
increased healthcare costs of comorbid depression
have been recognised.4
In the UK, the Quality and Outcomes Framework
provides incentives for GPs to use validated
questionnaires to identify people with depression,
including those with existing heart disease or
diabetes.5 The Patient Health Questionnaire (PHQ-9)6
and the depression subscale of the Hospital Anxiety
and Depression Scale (HADS-D)7 are increasingly
used to improve the identification and management
of people with depression among those with
diabetes or heart disease,8–10 but doctors’ responses
to the category scores vary, depending on which of
the questionnaires is used.11,12
Several studies show that PHQ-9 and HADS-D
differ in the proportion of people classified with mild,
moderate, or severe depression.13,14 A previous
study15 by the current authors identified the
prevalence of psychological disorders among people
with type 2 diabetes in Victoria, Australia, and used
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several indices of depression, distress, and anxiety.
This study reports the results of administering both
the PHQ-9 and HADS-D measures to all participants
and compares the performance of each in identifying
depression.
METHOD
Participants
Between February 2007 and March 2008, 1200
postal questionnaires were sent to 10 practices in
rural and metropolitan Victoria, Australia to distribute
to potential participants. Clinical data were recorded
by practice staff. Adults with type 2 diabetes from
seven general practices participated. A total of 561
completed questionnaires that could be matched
with clinical records were received, giving a response
rate of 46.8%.
Measures
The questionnaires asked about demographics,
diabetes, and depression. Clinical data included
glycosylated hemoglobin (HbA1c), body mass index
(BMI), and medications. The depression questionnaires
used were HADS-D and PHQ-9. Standard cut-off
scores were used with HADS-D to classify minimal
(0–7), mild (8–10), and moderate to severe (≥11) levels
of depression. For PHQ-9 the cut-off scores were:
minimal (0–4), mild (5–9), and moderate to severe (≥10).
Statistical analysis
Cronbach’s α and corrected item-total correlations
were used to examine internal consistency of items
on the two depression measures. Homogeneity and
structure of both scales were assessed using
principal components analysis. Additional analyses
included calculation of χ2, t-tests, and analysis of
variance to determine relationships between clinical
characteristics and depression scores (Stata
version 10).
RESULTS
Sample characteristics
The sample comprised 309 males (median age
67 years) and 252 females (median age 70 years).
Most were married (63%), from rural areas (75%),
educated to high-school level or less (69%), and either
retired or not in full-time employment (75%). Males
and females in the sample did not differ significantly in
age or level of education. There were no significant
differences between urban and rural responders with
regard to sex, age, level of education, employment
status, or health concessions.
Mean duration of diabetes for the sample was
8.84 years (standard deviation = 7.35 years). About
half the sample reported no diabetes complications
and a quarter reported two or more complications.
Most managed diabetes with oral medication only
(53.7%), or no medication (27.3%), but 107 (19.1%)
participants were taking insulin or insulin plus oral
medication. Previous history of depression was
reported by 161 participants; 48 of these had had an
episode within the previous 12 months, and 59 within
1–5 years. Current antidepressant usage was
reported by 65 of the 239 participants who had some
depression.
Responses to HADS-D and PHQ-9
depression measures
A higher proportion of the sample completed
HADS-D (96.8%) than PHQ-9 (82.4%; P<0.001). Of
the 561 patients who completed questionnaires, six
(1.1%) did not complete HADS-D but completed
PHQ-9, and 87 (15.5%) had missed items on PHQ-
9 but completed HADS-D. In total, 456 (81.3%)
participants completed both measures in full.
Response rates on both measures related to age:
older people (that is, those aged >65 years) had a
lower response rate than their younger counterparts
on both measures: HADS-D, P = 0.013; PHQ-9,
P<0.001 (Figure 1). Level of education was unrelated
to responses given on HADS-D, but was related to
those on PHQ-9 (P = 0.023), with lower response
rates shown for lower levels of education (that is,
high-school education or less).
Distribution of missing responses
The number of missing responses on individual
HADS-D items ranged from five to 11 (0.9% and
2.0% of the total sample respectively). Items with
close to 2% of missing responses on HADS-D were:
H3 ‘I feel cheerful’ (2%) and H1 ‘I still enjoy the things
I used to enjoy’ (1.8%).
On the individual PHQ-9 items, the number of
missing responses ranged from 43 to 58 (7.7% and
10.3% of the total sample respectively). PHQ-9 items
with close to 10% of missing responses were: P1
‘Little interest or pleasure in doing things’ (10.3%);
P2 ‘Feeling down, depressed, or hopeless’ (9.8%);
and P5 ‘Poor appetite or overeating’ (9.8%).
How this fits in
Clinical guidelines recommend screening patients with diabetes for depression
because of poor clinical outcomes when there is comorbid depression. The
depression subscale of the Hospital Anxiety and Depression Scale (HADS-D) and
the Patient Health Questionnaire (PHQ-9) are commonly used for screening in
primary care, but there is poor agreement between the measures in categorising
moderate to severe depression. When used to assess depression among patients
with type 2 diabetes, PHQ-9 may overestimate moderate to severe depression
because of items that include symptoms of diabetes or sleep disorders. HADS-D
is a better screening tool for depression in patients with diabetes.
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measures exceed 0.4 (HADS-D range 0.43 to 0.72,
PHQ-9 range 0.56 to 0.76). The figures given for
Cronbach’s α if items are deleted show that removal
of any of the individual items on HADS-D or PHQ-9
would not substantially improve the internal
reliabilities of the scales.
Factor structure
Factor analysis of the separate scales used principal
components. For HADS-D, the analysis gave one
factor with an eigenvalue of 3.49, which explained
49.8% of the total variance. For PHQ-9, a single
factor was obtained with an eigenvalue of 5.1,
explaining 56.8% of the total variance. Most items
within each scale had a substantial loading on the
primary factor (HADS-D range 0.56 to 0.83, PHQ-9
range 0.66 to 0.83).
A factor analysis including all items from both
HADS-D and PHQ-9 was also performed (Appendix
2.) The analysis yielded two factors with eigenvalues
of 7.8 and 1.2 respectively, which together explained
56.5% of the total variance. Items with substantial
loadings (>0.65) on factor 1 were: H4 ‘I feel as if I am
slowed down’; P3 ‘Trouble falling or staying asleep,
or sleeping too much’; P4 ‘Feeling tired or having
little energy’; and P5 ‘Poor appetite or overeating’.
The PHQ-9 items P1 ‘Little interest or pleasure in
doing things’ and P2 ‘Feeling down, depressed, or
hopeless’, loaded on both factors.
Comparison of severity ratings between
depression measures
The correlation between HADS-D and PHQ-9 was
significant at the 0.001 level (r = 0.78). The threshold
scores for mild and moderate to severe depression
were 8 and 11 respectively for HADS-D, and 5 and
10 respectively for PHQ-9. Although 117 (21.5%) of
those who completed HADS-D had some
depression (score >8), 186 (40.3%) of those who
completed PHQ-9 showed depression (score >5).
There were no significant sex differences across
severity categories on either of the measures, but
there were age differences. A higher proportion of
those aged 65 years and under (compared with
those over 65 years) reported moderate to severe
depression on both HADS-D (P = 0.029) and PHQ-9
(P = 0.008).
The cross tabulation of HADS-D and PHQ-9
scores in Table 1 shows a lack of concurrence of
distribution within severity cut-offs. Of the 103 cases
identified by PHQ-9 as moderate to severe, 35 were
in the same category on HADS-D, but 31 had
minimal depression on HADS-D. Of the 40 identified
by HADS-D in the moderate to severe range, PHQ-9
classified 35 as moderate to severe and two cases
as minimal depression.
Reliability analysis
Cronbach’s α coefficients and item-total correlations
are given in Appendix 1. Coefficient α for both
scales are acceptable and comparable with
previous studies of these measures in samples from
primary care. All item-total correlations within both
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Figure 1. Distribution of depression severity among
patients with diabetes assessed on the depression
subscale of the Hospital Anxiety and Depression Scale
(HADS-D, n = 543) and the Patient Health Questionnaire
(PHQ-9, n = 462).
PHQ-9
Minimal (0–4) Mild (5–9) Moderate to severe (≥10) Total
HADS-D n n n n
Minimal (0–7) 262 68 31 361
Mild (8–10) 7 11 37 55
Moderate to 2 3 35 40
severe (≥11)
Total 271 82 103 456
HADS-D = depression subscale of the Hospital Anxiety and Depression Scale. PHQ-9 =
Patient Health Questionnaire.
Table 1. Cross tabulation of scores across depression
measures and severity ratings reported by primary care
patients with type 2 diabetes.
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Figure 2. Distribution of responses for maximum score 3 on individual items of the
depression subscale of the Hospital Anxiety and Depression Scale (HADS-D) by
depression severity: minimal n = 426, mild n = 66, moderate to severe n = 51. H1–H7 refers
to individual question items (see Appendices 1 and 2).
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Figure 3. Distribution of responses for maximum score 3 on individual items of the Patient
Health Questionnaire (PHQ-9) by depression severity: minimal n = 276, mild n = 82, moderate
to severe n = 104. P1–P9 refers to individual question items (see Appendices 1 and 2).
Distribution of expected and observed item
responses by severity cut-offs
On both measures, the maximum possible rating for
each item was 3, indicating highest frequency of
occurrence (this was ‘nearly all the time’ on HADS-
D, and ‘nearly every day’ on PHQ-9). The expected
proportion of maximum ratings for each item within
each total score, y = a/b, was calculated by
determining, for each possible total score, (a) the
number of ways in which the total score could be
arrived at while keeping a particular item fixed at the
maximum and (b) the overall number of ways in
which the total score could be arrived at. Means of
expected proportions were calculated for each
depression severity to be compared with the
observed proportion by using 95% confidence
intervals.
Figures 2 and 3 show the distribution of item
responses by severity cut-offs on HADS-D and
PHQ-9 respectively. Only one HADS-D item and two
PHQ-9 items showed over 50% of moderate to
severe category responses on the maximum rating:
H4 ‘I feel as if I am slowed down’; P3 ‘Trouble falling
or staying asleep, or sleeping too much’; and P4
‘Feeling tired or having little energy’. The proportions
of observed responses to these items were
significantly higher than their corresponding
expected responses.
Clinical characteristics and depression scores
Table 2 shows the mean scores on the two
depression measures by diabetes and depression
clinical characteristics. Duration of diabetes was
related to both HADS-D (P<0.001) and PHQ-9
(P = 0.026) scores, with greater duration (≥5 years)
linked to higher depression. A greater number of
diabetes complications was related to higher scores
on HADS-D (P<0.001) and PHQ-9 (P<0.001). Use of
medication, either oral or oral plus insulin, was
related to higher HADS-D scores (P<0.001) and
higher PHQ-9 scores (P = 0.004). Depression scores
were unrelated to recent HbA1c levels in patients’
clinical records. Obesity (BMI >30 kg/m2) was
related to higher depression on both HADS-D (P =
0.002) and PHQ-9 (P = 0.001). Participants who had
a previous episode of depression showed higher
scores on HADS-D (P<0.001) and PHQ-9 (P<0.001),
as did those being prescribed antidepressants at the
time of the study (HADS-D, P<0.001; PHQ-9,
P<0.001).
DISCUSSION
Summary of main findings
Both the HADS-D and PHQ-9 measures demonstrated
acceptable reliability and robustness of factor
structure. Both questionnaires can be self-
PHQ-9 items found the HADS-D item ‘feel slowed
down’, together with the PHQ-9 items concerning
sleeping, tiredness, and poor appetite or overeating,
showed high loadings on the first factor. These results
suggest somatic symptoms and behaviours related to
diabetes may be contributing to the depression
scores, particularly when measured using PHQ-9.
Strengths and limitations of the study
This is a singular comparison of responses to PHQ-9
and HADS-D measures among participants with
diagnosed type 2 diabetes in primary care, providing
a snapshot of what GPs are likely to encounter in
everyday practice. The study demonstrates that both
measures can be used for screening through self-
completion of a postal questionnaire, but that HADS-
D appears to provide a more accurate view. The
prevalence of depression with HADS-D is similar to
other epidemiological studies in the region.15,16
Gold standards such as the Structured Clinical
Interview for DSM-IV17 were beyond the scope of the
study but could probably have further clarified which
measure performed better for screening. The sample
was selected because of type 2 diabetes status. This
study did not have a comparison sample that had
depression but not diabetes, but the factor analysis of
pooled HADS-D and PHQ-9 items for this group of
patients with diabetes showed a different pattern of
item loadings when compared with a similar analysis
of primary care patients without diabetes in Sweden.14
Comparison with existing literature
The psychometric properties of the HADS-D and
PHQ-9 depression measures in this Australian
population with type 2 diabetes are similar to those
reported in samples of patients in primary care in the
UK11,13 and Sweden.14 Comparing the two measures,
PHQ-9 identified more than twice as many in the
moderate to severe category as HADS-D, a pattern
that has been noted in other studies.11,13,14 Other
authors reported that these large differences in
categorisation are not reflected in prescribing because
GPs take other things, such as history of depression,
into account along with the questionnaire score.11,12
One study showed that although PHQ-9
categorised 83.5% of patients as having moderate to
severe depression compared with 55% by HADS-D,
prescription rates were almost identical at 79%, and
referral rates at 23.7% and 20.3% respectively.11 The
study also reported lower treatment rates among
patients with heart disease or diabetes.
Implications for clinical practice and future
research
Patients appear to value these self-report measures,
which they regard as objective and offering them a
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administered and completed within a few minutes, but
HADS-D seems to be a better tool for self-
administered screening than PHQ-9. This is because
response rates for PHQ-9, but not HADS-D, appear to
be influenced by level of education and because the
distribution of responses on individual items on PHQ-9
showed more missing responses. Some 10% were
missing on the first two items; these make up the PHQ-
2 test, which is sometimes used for rapid screening.
Using the recommended severity scores, the
PHQ-9 tool (scores >5) identified about 20% more
patients as having depression compared with HADS-
D (scores >8). Only about a third (34%) of the cases
identified by PHQ-9 in the moderate to severe
depression category was located in the same
category by HADS-D.
This study confirms the poor agreement between
PHQ-9 and HADS-D measures for classifying severity
of depression. The explanation for the higher
proportion categorised as moderate to severe by
PHQ-9 comes from responses to two items concerned
with sleeping problems and tiredness or having little
energy, which received a rating 3 (experienced nearly
every day) by over 50% of the sample. Similarly, the
‘feel slowed down’ item on HADS-D was endorsed by
over 60% of those in the moderate to severe category
with the maximum rating.
The factor analysis of the pooled HADS-D and
HADS-D PHQ-9
n Mean SD n Mean SD
Diabetes duration
<5 years 170 3.62 3.55 151 4.56 5.85
≥5 years 345 5.25 3.97 290 5.94 6.32
Diabetes complications
None 266 3.79 3.61 233 4.35 5.63
One 146 4.94 3.51 121 5.35 5.89
Two or more 131 6.20 4.24 108 7.95 6.67
Diabetes regimen
No medication 148 3.73 3.59 133 4.56 5.78
Oral only 249 4.75 3.90 244 5.28 6.14
Insulin or insulin + oral 101 5.89 3.82 85 7.34 6.21
Recent HbA1c
>7 146 4.86 4.19 132 6.11 6.87
≤7 214 4.53 3.72 182 5.26 5.84
Body mass index (kg/m2)
≤30 221 4.02 3.53 189 4.26 5.34
>30 217 5.13 4.05 198 6.39 6.54
Previous depression
Yes 158 6.49 4.48 143 8.82 6.83
No 385 3.94 3.31 319 3.94 5.09
Current antidepressant medication
Yes 63 7.38 4.48 59 10.78 7.60
No 480 4.33 3.64 403 4.67 5.45
HADS-D = depression subscale of Hospital Anxiety and Depression Scale. HbA1c =
glycosylated hemoglobin. PHQ-9 = Patient Health Questionnaire.
Table 2. Clinical characteristics and depression scores.
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means to express how they feel. GPs, however, may
see depression questionnaires simply as guides to
decision making.12 GPs appear more inclined to
accept a HADS-D score at face value than a PHQ-9
one. This is reflected in the similar rates of
prescribing and referral, even though PHQ-9 seems
to be used three times more often than HADS-D.11
Perhaps GPs are taking into account the fact that
PHQ-9 overestimates severity because it includes
somatic symptoms that GPs are willing to attribute to
the underlying condition rather than depression.
The two items forming PHQ-2 seem particularly
unsuitable for screening patients with diabetes.
They both had a high proportion of missing
responses and so could not be used to classify
patients with diabetes who also have moderate to
severe depression.
There has been considerable progress in screening
people with diabetes for depression.8,9 The current
results suggest that PHQ-9 overestimates
depression among patients with diabetes because it
contains questions about tiredness, sleeping
problems, and eating patterns that are common in
diabetes. There is a complicated relationship
between obesity, diabetes, depression, and
obstructive sleep apnoea.18,19 Sleep disturbances in
diabetes are frequently due to nocturia, neurogenic
pain, and other causes.20,21 The PHQ-9 questions
about over eating or under eating, and the somatic
symptom of tiredness may be accounted for by
diabetes itself, or by sleep disturbances including
obstructive sleep apnoea, and could account for the
high classification rate for moderate to severe
depression.
HADS-D is probably a better screening instrument
for patients with type 2 diabetes. If using PHQ-9,
GPs should assess each of the patient’s nine
answers and consider causes of sleep disorder or
tiredness besides depression. Focusing on individual
responses, rather than total scores, may prove more
effective in reducing suffering and accurately
identifying the problems encountered by the patient.22
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Item-total Coefficient α Cronbach’s α
Scale and items correlations (95% CI) if item deleted
HADS-D (n = 543) 0.83 (0.80 to 0.85)
H1 Still enjoy things 0.63 0.79
H2 Can laugh 0.59 0.80
H3 Feel cheerful 0.59 0.80
H4 Feel slowed down 0.50 0.82
H5 Lost interest in appearance 0.57 0.80
H6 Look forward with enjoyment 0.72 0.78
H7 Can enjoy book/radio/TV 0.43 0.82
PHQ-9 (n = 462) 0.90 (0.88 to 0.91)
P1 Little interest or pleasure in doing things 0.76 0.88
P2 Feeling down, depressed, hopeless 0.75 0.88
P3 Trouble sleeping or sleeping too much 0.66 0.89
P4 Feeling tired or having little energy 0.75 0.88
P5 Poor appetite or overeating 0.63 0.89
P6 Feeling bad about self, or a failure, or have let self or family down 0.71 0.88
P7 Trouble concentrating, such as reading newspaper or watching TV 0.66 0.89
P8 Moving or speaking more slowly, or being restless, moving more than usual 0.61 0.89
P9 Thoughts of self-harm 0.56 0.90
HADS-D = depression subscale of the Hospital Anxiety and Depression Scale. PHQ-9 = Patient Health Questionnaire.
Appendix 1. Cronbach’s α and item-total correlations of the HADS-D and PHQ-9.
Scale Item Factor 1 Factor 2
HADS-D
H1 Still enjoy things 0.594 0.338
H2 Can laugh 0.371 0.631
H3 Feel cheerful 0.343 0.670
H4 Feel slowed down 0.752 0.046
H5 Lost interest in appearance 0.560 0.299
H6 Look forward with enjoyment 0.562 0.568
H7 Can enjoy book/radio/TV 0.073 0.664
PHQ-9
P1 Little interest or pleasure in doing things 0.610 0.568
P2 Feeling down, depressed, hopeless 0.581 0.532
P3 Trouble sleeping or sleeping too much 0.657 0.306
P4 Feeling tired or having little energy 0.795 0.278
P5 Poor appetite or overeating 0.704 0.237
P6 Feeling bad about self, or a failure, or have let self or family down 0.531 0.571
P7 Trouble concentrating, such as reading newspaper or watching TV 0.267 0.768
P8 Moving or speaking more slowly, or being restless, moving more than usual 0.296 0.648
P9 Thoughts of self-harm 0.203 0.706
HADS-D = depression subscale of the Hospital Anxiety and Depression Scale. PHQ-9 = Patient Health Questionnaire. Figures
in bold are items with high (>0.500) loadings on each factor.
Appendix 2. Factor analysis loadings with varimax rotation of pooled items from
HADS-D and PHQ-9 measures of depression.
